Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders

被引:16
作者
Fiandaca, Massimo S. [1 ]
Lonser, Russell R. [2 ]
Elder, J. Bradley [2 ]
Zabek, Miroslaw [3 ]
Bankiewicz, Krystof S. [1 ,2 ,3 ]
机构
[1] Brain Neurotherapy Bio Inc, Oakland, CA USA
[2] Ohio State Univ, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA
[3] Brodno Mazovia Hosp, Intervent Neuro Ctr INC, Warsaw, Poland
关键词
gene therapy; convection-enhanced delivery; Parkinson's Disease; clinical neuroscience education; robotics; artificial intelligence; CONVECTION-ENHANCED DELIVERY; MULTIPLE SYSTEM ATROPHY; PROGRESSIVE SUPRANUCLEAR PALSY; TRANSGENIC MOUSE MODEL; MPTP-LESIONED PRIMATES; REAL-TIME; DOUBLE-BLIND; SUBSTANTIA-NIGRA; NATURAL-HISTORY; ALPHA-SYNUCLEIN;
D O I
10.5603/PJNNS.a2020.0046
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Vector-based intracerebral gene therapies are being used to treat specific neurodegenerative conditions such as Parkinson's Disease (PD). This review presents a basis for central nervous system (CNS) gene therapy treatments of neurodegenerative diseases such as PD, as well as the need for novel skill sets and health delivery strategies within the clinical neurosciences (neurology and neurosurgery) to meet future demand for such therapies. State of the art. Preclinical vector-based gene therapy approaches have been translated into clinical trials for PD and other neurodegenerative conditions. Unfortunately, such trials, and parallel efforts using other therapeutics, have yet to provide a breakthrough. Image-guided convection enhanced delivery (CED) optimises the parenchymal distribution of gene therapies applied within the CNS, and may ultimately provide such a breakthrough. Clinical implications. Currently, image-guided CED and gene therapy are not part of training programmes for most neurosurgeons and neurologists. As a result, few medical centres and hospitals have sufficiently experienced teams to participate in gene transfer clinical trials for PD or other neurological conditions. If CNS gene therapies prove to be efficacious for PD and/or other conditions, the demand for such treatments will overwhelm the available number of experienced clinical neuroscience teams and treatment centres. Future directions. Expanded indications and demand for CNS gene therapies will require a worldwide educational effort to supplement the training of clinical neuroscience practitioners. Initially, a limited number of Centres of Excellence will need to establish relevant educational training requirements and best practice for such therapeutic approaches. Advanced technologies, including robotics and artificial intelligence, are especially germane in this regard, and will expand the treatment teams capabilities while assisting in the safe and timely care of those afflicted.
引用
收藏
页码:220 / 231
页数:12
相关论文
共 106 条
[61]   Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease [J].
Mittermeyer, Gabriele ;
Christine, Chadwick W. ;
Rosenbluth, Kathryn H. ;
Baker, Suzanne L. ;
Starr, Philip ;
Larson, Paul ;
Kaplan, Paul L. ;
Forsayeth, John ;
Aminoff, Michael J. ;
Bankiewicz, Krystof S. .
HUMAN GENE THERAPY, 2012, 23 (04) :377-381
[62]   HIGH-FLOW MICROINFUSION - TISSUE PENETRATION AND PHARMACODYNAMICS [J].
MORRISON, PF ;
LASKE, DW ;
BOBO, H ;
OLDFIELD, EH ;
DEDRICK, RL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (01) :R292-R305
[63]   The global neurosurgical workforce: a mixed-methods assessment of density and growth [J].
Mukhopadhyay, Swagoto ;
Punchak, Maria ;
Rattani, Abbas ;
Hung, Ya-Ching ;
Dahm, James ;
Faruque, Serena ;
Dewan, Michael C. ;
Peeters, Sophie ;
Sachdev, Sonal ;
Park, Kee B. .
JOURNAL OF NEUROSURGERY, 2019, 130 (04) :1142-1148
[64]   Image-guided convection-enhanced delivery of gemcitabine to the brainstem [J].
Murad, Gregory J. A. ;
Walbridge, Stuart ;
Morrison, Paul F. ;
Szerlip, Nicholas ;
Butman, John A. ;
Oldfield, Edward H. ;
Lonser, Russell R. .
JOURNAL OF NEUROSURGERY, 2007, 106 (02) :351-356
[65]   Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to Pseudomonas exotoxin [J].
Murad, Gregory J. A. ;
Walbridge, Stuart ;
Morrison, Paul F. ;
Garmestani, Kayhan ;
Degen, Jeffrey W. ;
Brechbiel, Martin W. ;
Oldfield, Edward H. ;
Lonser, Russell R. .
CLINICAL CANCER RESEARCH, 2006, 12 (10) :3145-3151
[66]  
Neurosurgery US, 2012, C NEUR SURG SOC NEUR
[67]   Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity [J].
Niethammer, Martin ;
Tang, Chris C. ;
Vo, An ;
Nguyen, Nha ;
Spetsieris, Phoebe ;
Dhawan, Vijay ;
Ma, Yilong ;
Small, Michael ;
Feigin, Andrew ;
During, Matthew J. ;
Kaplitt, Michael G. ;
Eidelberg, David .
SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (469)
[68]   Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD [J].
Nutt, JG ;
Burchiel, KJ ;
Comella, CL ;
Jankovic, J ;
Lang, AE ;
Laws, ER ;
Lozano, AM ;
Penn, RD ;
Simpson, RK ;
Stacy, M ;
Wooten, GF .
NEUROLOGY, 2003, 60 (01) :69-73
[69]   Gene therapy for neurodegenerative diseases [J].
O'Connor, Deirdre M. ;
Boulis, Nicholas M. .
TRENDS IN MOLECULAR MEDICINE, 2015, 21 (08) :504-512
[70]   Clinical outcomes of progressive supranuclear palsy and multiple system atrophy [J].
O'Sullivan, S. S. ;
Massey, L. A. ;
Williams, D. R. ;
Silveira-Moriyama, L. ;
Kempster, P. A. ;
Holton, J. L. ;
Revesz, T. ;
Lees, A. J. .
BRAIN, 2008, 131 :1362-1372